Clinical Microbiology and Infection
LightNews LightNews
banner
cmijournal.bsky.social
Clinical Microbiology and Infection
@cmijournal.bsky.social
2.8K followers 21 following 19 posts
CMI, the official publication of ESCMID, is a monthly peer-reviewed medical journal publishing applied and basic research in the field of clinical microbiology and infectious diseases #IDSky #MicroSky

https://www.clinicalmicrobiologyandinfection.com/
Posts Replies Media Videos
Reposted by Clinical Microbiology and Infection
escmid.bsky.social
The Clinical Microbiology and Infection launched a collection, Reviews on Research Methods, providing accessible and authoritative reviews. We invite our community to contribute to 'How to get it right' series, featured in this collection. Learn more: https://ow.ly/T28n50Xr1ky

#IDSky #clinmicro
November 15, 2025 at 12:35 PM
cmijournal.bsky.social
💡CMI is looking to get your feedback
Take the readership survey by using the link below to help us ensure that CMI is fulfilling your needs. ow.ly/E3CF50XohaT

⏰The survey is open until 15 December.
November 10, 2025 at 4:11 PM
Reposted by Clinical Microbiology and Infection
escmid.bsky.social
The Editor-in-Chief of Clinical Microbiology and Infection, Leonard Leibovici, will be stepping down and replaced by Jesús Rodríguez Baño on 1 Jan 2026. Read their editorials plus one by our Publications Counsellor:
https://ow.ly/Zw1W50XkPnb
https://ow.ly/HxA350XkPno
https://ow.ly/REKB50XkPnf
#IDSky
November 1, 2025 at 11:05 AM
cmijournal.bsky.social
November 2025 Issue is now online: www.clinicalmicrobiologyandinfection.org/issue/S1198-...
#IDSky #MicroSky
October 24, 2025 at 8:04 AM
Reposted by Clinical Microbiology and Infection
drandrekalil.bsky.social
💥🆕“Plasma Microbial Cell-Free DNA Sequencing in Transplant and Hematologic Patients—Promise, Pitfalls, and Path Forward”
👇Free Access
bit.ly/3KzihEu
@cmijournal.bsky.social #IDSky #MedSky #PCCSky #EMIMC #AMSSky #TxID #meded #Pharmsky #RXSky #MicroSky #ClinMicro @unmc.bsky.social @unmc-id.bsky.social
Plasma microbial cell-free DNA sequencing in transplant and haematologic patients—promise, pitfalls, and path forward
bit.ly
October 8, 2025 at 10:58 PM
Reposted by Clinical Microbiology and Infection
seanong.bsky.social
Our new paper in @cmijournal.bsky.social led by the brilliant Hadrien Moffroid, a junior colleague in Melbourne. We examined international funding flows in ID RCTs published in selected high-impact journals over a 10-year period.

doi.org/10.1016/j.cm...
@steventong.bsky.social #IDSky
Heat map of countries funding ID clinical trials and countries where ID clinical trials are conducted.
September 29, 2025 at 8:57 AM
Reposted by Clinical Microbiology and Infection
unmc-id.bsky.social
Drs. Gomez, Scherger, Abbas & @drandrekalil.bsky.social published a fascinating paper in @cmijournal.bsky.social on novel diagnostic testing:

"Plasma Microbial Cell-Free DNA Sequencing in Transplant and Hematologic Patients-Promise, Pitfalls, and Path Forward"

pubmed.ncbi.nlm.nih.gov/40946803/
Plasma Microbial Cell-Free DNA Sequencing in Transplant and Hematologic Patients-Promise, Pitfalls, and Path Forward - PubMed
Plasma Microbial Cell-Free DNA Sequencing in Transplant and Hematologic Patients-Promise, Pitfalls, and Path Forward
pubmed.ncbi.nlm.nih.gov
September 25, 2025 at 7:50 PM
Reposted by Clinical Microbiology and Infection
escmid.bsky.social
@cmijournal.bsky.social wants your feedback! Take the readership survey by using the link below to help us ensure that our journal is fulfilling your needs. The survey is open until 30 November.
survey.us.confirmit....
September 21, 2025 at 10:01 AM
Reposted by Clinical Microbiology and Infection
elsevierhms.bsky.social
Help shape the future of Clinical Microbiology and Infection. Participate in the CMI readership survey: spkl.io/63324APKAu
http://spkl.io/63323APKAP
Participate in the CMI readership survey to help shape the future of Clinical Microbiology and Infection.
spkl.io
September 4, 2025 at 11:00 AM
cmijournal.bsky.social
October 2025 Issue is now online: www.clinicalmicrobiologyandinfection.org/issue/S1198-... #IDSky #MicroSky
September 16, 2025 at 5:25 AM
Reposted by Clinical Microbiology and Infection
unmc-id.bsky.social
Drs. Scherger, Gomez, Abbas, and @drandrekalil.bsky.social paired up for this review in @cmijournal.bsky.social for this narrative review on COVID-19 phenotypes #IDSky

www.clinicalmicrobiologyandinfection.org/article/S119...
Decoding COVID-19: Phenotypes and the Pursuit of Precision Medicine
The pursuit of personalized medicine has underscored the critical role of phenotypes and sub-phenotypes in biology and medicine. A growing body of literature has identified diverse phenotypic manifest...
www.clinicalmicrobiologyandinfection.org
September 8, 2025 at 5:46 PM
cmijournal.bsky.social
Help shape the future of the journal
Participate in the CMI readership survey: bit.ly/4n0FUUR
September 1, 2025 at 2:43 PM
cmijournal.bsky.social
September 2025 Issue is now online: www.clinicalmicrobiologyandinfection.org/issue/S1198-...
August 24, 2025 at 5:05 AM
Reposted by Clinical Microbiology and Infection
abhishekdp.bsky.social
Excited to share our work on the epidemiology of diarrheal pathogens using multiplex PCR gastrointestinal panels, led by the amazing medical student, Jeffrey Shu and now published in @cmijournal.bsky.social! 🎉 Kudos to all! #CCLCM #AWSOM shorturl.at/kTWqt
August 20, 2025 at 4:00 AM
Reposted by Clinical Microbiology and Infection
escmid.bsky.social
Our two journals, CMI and CMI Communications, have open calls for editorial fellows. Read more about their respective programmes on their webpages and deadlines:
CMI @cmijournal.bsky.social ow.ly/HTBL50WBUfv
CMI Comms @cmicomms.bsky.social ow.ly/FJkF50WBUfz

#IDSky #clinmicro
August 10, 2025 at 3:58 PM
Reposted by Clinical Microbiology and Infection
bhmullish.bsky.social
Very pleased to see this out in @cmijournal.bsky.social - what non-antimicrobial options are there for recurrent #UTI, and what might be the role for #FMT? www.clinicalmicrobiologyandinfection.com/article/S119... @rohmaghani.bsky.social @imperialmdr.bsky.social @imperialbrc.bsky.social #MicroSky
https://clinicalmicrobiologyandinfection.com/article/S1198-…
July 29, 2025 at 10:21 PM
Reposted by Clinical Microbiology and Infection
drtimothyli.bsky.social
Narrative review on fungal diagnostics @cmijournal.bsky.social

doi.org/10.1016/j.cm...

#IDSky
July 26, 2025 at 8:58 AM
cmijournal.bsky.social
August 2025 Issue is now online: www.clinicalmicrobiologyandinfection.com/issue/S1198-... #IDSky #MicroSky
July 24, 2025 at 4:48 PM
Reposted by Clinical Microbiology and Infection
gpollara.bsky.social
🎯 Interesting recurrent UTI study with intriguing results:

Methenamine (Hiprex):

- Starting 👉 ⤵️ frequency of rUTIs in older women
-Stopping 👉 ⤴️ risk of UTI relapses

Many questions:
- mechanism?
- change symptom perception?
- rebound seen also in other Rx?
#UTISky #IDSky @cmijournal.bsky.social
Methenamine hippurate as prophylaxis for recurrent urinary tract infections in older women – a triple-blind, randomised, placebo-controlled, phase IV trial (ImpresU).
To investigate the preventive effect of the antiseptic methenamine hippurate on recurrent urinary tract infections (rUTIs) in older women.
www.clinicalmicrobiologyandinfection.com
July 15, 2025 at 6:56 AM
Reposted by Clinical Microbiology and Infection
jonathanrydermd.bsky.social
New RCT in @cmijournal.bsky.social for #UTISky:

Methenamine vs placebo for recurrent UTI PPx (n=281)

Methenamine ⬇️ antibiotic tx for UTI: IRR 0.75 (95% CI 0.57-1.0, p= 0.049)

But methenamine group had ⬆️ abx use in 6m follow-up after dc'ing

www.clinicalmicrobiologyandinfection.com/article/S119...
Methenamine hippurate as prophylaxis for recurrent urinary tract infections in older women – a triple-blind, randomised, placebo-controlled, phase IV trial (ImpresU).
To investigate the preventive effect of the antiseptic methenamine hippurate on recurrent urinary tract infections (rUTIs) in older women.
www.clinicalmicrobiologyandinfection.com
July 15, 2025 at 2:57 AM
cmijournal.bsky.social
July 2025 Issue is now online: www.clinicalmicrobiologyandinfection.com/issue/S1198-...
July 1, 2025 at 4:46 PM
cmijournal.bsky.social
Are you a young or early-career researcher working in clinical microbiology and infectious diseases using epidemiological and statistical methods? Enlist in the workshop on research methods organized by CMI/ESCMID/ECRAID:
ecraid.eu/news/postgra...
Postgraduate Course 2025: Better Methods for Clinical Studies | Ecraid
The course takes place on 28-30 October 2025 in Athens, Greece.
ecraid.eu
June 30, 2025 at 8:33 AM
Reposted by Clinical Microbiology and Infection
fredericauvray.bsky.social
I’m happy to announce our publication in @CMIJournal.bsky.social , focusing on emerging pathogenic E. coli O80:H2 and the role of humans as a potential reservoir for these atypical « hybrid » strains #ecoli #stec #expec #genomics #reservoir
www.clinicalmicrobiologyandinfection.com/article/S119...
Re: Humans as a potential reservoir for the emerging ST301 Shiga toxin-producing Escherichia coli clones of serotype O80:H2?
Shiga toxin (Stx)-producing Escherichia coli (STEC) are responsible for a wide range of diseases in humans, from mild diarrhoea to severe haemorrhagic colitis and haemolytic uremic syndrome (HUS). The...
www.clinicalmicrobiologyandinfection.com
June 13, 2025 at 9:46 AM
Reposted by Clinical Microbiology and Infection
germhuntermd.bsky.social
Diagnosis and Management of Candida Endophthalmitis and Chorioretinitis

Nate Permpalung, Sarah Sedik, Pete Pappas, @martinhoenigl.bsky.social, @drluiso.bsky.social in @cmijournal.bsky.social

www.clinicalmicrobiologyandinfection.com/article/S119...
Diagnosis and Management of Candida Endophthalmitis and Chorioretinitis
Candida endophthalmitis and chorioretinitis are uncommon but potentially devastating complications of candidemia, associated with significant risks of vision loss and long-term morbidity. Effective ma...
www.clinicalmicrobiologyandinfection.com
June 2, 2025 at 11:20 PM
Reposted by Clinical Microbiology and Infection
germhuntermd.bsky.social
Fungal infections in patients with hematologic malignancies in the pre-triazole era: The dawn of a new era in medical mycology

Umut Akova, Rachel Hicklen, Russell E. Lewis, Thomas J. Walsh, Dimitrios P. Kontoyiannis

@cmijournal.bsky.social

www.clinicalmicrobiologyandinfection.com/article/S119...
Figure. (a-b): Milestones since the dawn of medical mycology. (a) Major events in supportive care of patients with hematologic cancer pertaining to mycology (b) Timeline of introduction of new antifungals.
June 10, 2025 at 3:53 PM